Maddalena Adorno | Targeting Ageing: Emerging Therapeutic Strategies | Milan Longevity Summit 2026

*Modulation of an Epigenetic Regulator for the Treatment of Age-Related Disease* Can we influence the way our cells age without changing their DNA? In this session from *Targeting Ageing: Emerging Therapeutic Strategies* at the *Milan Longevity Summit 2026*, *Dr. Maddalena Adorno* explores how targeting epigenetic regulation could open a new generation of therapies for age-related disease. Ageing changes not only our cells, but also how genes are regulated and expressed. Epigenetic mechanisms help determine which genetic programmes cells activate, influencing their ability to maintain function, repair damage, and regenerate over time. Dr. Adorno presents an emerging therapeutic approach based on modulating an epigenetic regulator to restore healthier cellular function. The research points towards a future in which therapies could target fundamental mechanisms of ageing rather than addressing individual diseases in isolation. Dr. Maddalena Adorno is Co-Founder and CEO of *Dorian Therapeutics*, a biotechnology company developing therapeutics targeting the biology of ageing and age-related diseases. Her work bridges stem cell biology, epigenetics, regenerative medicine, and biotechnology, with the goal of translating discoveries in ageing biology into new medicines. The Milan Longevity Summit brings together global leaders across science, medicine, policy, business, technology and society to rethink the future of health through a *One Health* perspective—recognising that the wellbeing of people, planet and economies is deeply interconnected. *Learn more about the Milan Longevity Summit:* https://www.milanlongevitysummit.org/speakers26/maddalena-adorno #MilanLongevitySummit #Longevity #OneHealth #MaddalenaAdorno #Epigenetics #AgeRelatedDisease #RegenerativeMedicine #LongevityBiotech #HealthyAgeing #Healthspan